SMYAD was reported to reduce the atherosclerosis plaque area, promote the recruitment of vasa vasorum pericytes, and stabilize atherosclerosis vulnerable plaques in ApoE-/- mice (Qi et al., 2019). Here, APOE is linked to atherosclerosis.